CN106047916A - Corynebacterium glutamicum strain for production of 5-aminolevulinic acid and construction and application of corynebacterium glutamicum strain - Google Patents

Corynebacterium glutamicum strain for production of 5-aminolevulinic acid and construction and application of corynebacterium glutamicum strain Download PDF

Info

Publication number
CN106047916A
CN106047916A CN201610408674.4A CN201610408674A CN106047916A CN 106047916 A CN106047916 A CN 106047916A CN 201610408674 A CN201610408674 A CN 201610408674A CN 106047916 A CN106047916 A CN 106047916A
Authority
CN
China
Prior art keywords
strain
corynebacterium glutamicum
gene
plasmid
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610408674.4A
Other languages
Chinese (zh)
Inventor
王智文
冯丽丽
陈涛
赵学明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University
Original Assignee
Tianjin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University filed Critical Tianjin University
Priority to CN201610408674.4A priority Critical patent/CN106047916A/en
Publication of CN106047916A publication Critical patent/CN106047916A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/77Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0008Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01027L-Lactate dehydrogenase (1.1.1.27)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01028D-Lactate dehydrogenase (1.1.1.28)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • C12Y401/01032Phosphoenolpyruvate carboxykinase (GTP) (4.1.1.32)

Abstract

The invention discloses a corynebacterium glutamicum strain for production of 5-aminolevulinic acid and construction and application of corynebacterium glutamicum strain. A construction method includes: (1) deleting a lactic dehydrogenase coding gene 1dhA and acetic acid generation genes pta-ackA, pqo and cat in corynebacterium glutamicum to obtain a strain named CB4; inserting a strong sod promoter in front of a phosphoenolpyruvate carboxylase coding gene ppc in the strain CB4 to obtain a strain CB5; deleting a gene pck in the strain CB5 to obtain a strain CB6; (2) transferring plasmid pXA and plasmid pEP2<tuf>-rhtA into the strain CB6. The strain constructed according to the method is capable of generating 2.78g/L 5-aminolevulinic acid in a culture medium with 10g/L glucose serving as a carbon source, which lays a foundation for subsequent continuous feeding of a fermentation tank to increase yield of the 5-aminolevulinic acid.

Description

Produce the Corynebacterium glutamicum strain of 5-ALA and structure and application
Technical field
The invention belongs to biotechnology and application, more particularly to a kind of paddy ammonia producing 5-ALA Acid coryneform bacterial strains and structure and application.
Background technology
5-ALA, molecular weight is 131.13, and fusing point is 118 DEG C.It it is a kind of non-protein amino acid.5-amino second Acyl propanoic acid has that side effect is little, good penetrability feature, be widely used in skin carcinoma, bladder cancer, digestive tract cancer, In the diagnosis of pulmonary carcinoma and optical dynamic therapy (PDT).Meanwhile, 5-ALA is the most also having critically important application such as As plant growth regulator, herbicide and environment friendly agricultural etc..
In nature, 5-ALA biosynthesis mainly has following two approach: i.e. C4 approach and C5 approach. C4 approach is to be condensed generation 5-ALA under 5-Aminolevulinate synthase effect by succinyl CoA and glycine, This approach is present in animal, fungus and non-sulfur photosynthetic bacteria.C5 approach is then under tRNA participates in, through three-step reaction Catalysis generates 5-ALA, and this approach is widely present in plant, algae and antibacterial, including escherichia coli and paddy ammonia Acid bar bacterium.
At present, only have and utilize C5 approach to produce the report of 5-ALA about Corynebacterium glutamicum on a small quantity, but This approach is more complicated, and yield and the yield of 5-ALA are the lowest.
According to retrieval, the most not yet it is related to Corynebacterium glutamicum and utilizes C4 approach to produce the report of 5-ALA.
Summary of the invention
It is an object of the invention to overcome the deficiencies in the prior art, it is provided that a kind of glutamic acid rod producing 5-ALA The construction method of bacillus strain.
Second object of the present invention is to provide a kind of Corynebacterium glutamicum strain producing 5-ALA.
Third object of the present invention is to provide answering of a kind of Corynebacterium glutamicum strain producing 5-ALA With.
Technical scheme is summarized as follows:
The construction method of a kind of Corynebacterium glutamicum strain producing 5-ALA, comprises the steps:
(1) in Corynebacterium glutamicum (C.glutamicum) ATCC 13032, lactic dehydrogenase enzyme coding gene ldhA is knocked out Generating gene pta-ackA, pqo and cat with acetic acid, the Strain Designation obtained is CB4;Phosphoenolpyruvate third in CB4 bacterial strain Keto acid carboxylase encoding gene ppc is previously inserted into strong sod promoter, obtains bacterial strain CB5;Phosphoric acid alkene is knocked out in CB5 bacterial strain Alcohol of formula pyruvate carboxykinase encoding gene pck, obtains bacterial strain CB6;
(2) the plasmid pXA and process LAN RhtA of the process LAN 5-Aminolevulinate synthase gene built are transported egg White plasmid pEP2tuf-rhtA is transferred in CB6 bacterial strain, it is thus achieved that produce the Corynebacterium glutamicum strain of 5-ALA AL2。
The Corynebacterium glutamicum strain AL2 producing 5-ALA that said method builds.
The use of the Corynebacterium glutamicum strain AL2 fermenting and producing 5-ALA of above-mentioned production 5-ALA On the way.Beneficial effect
The present invention constructs a strain and utilizes C4 approach to produce the Corynebacterium glutamicum strain of 5-ALA, this bacterial strain Can produce 2.78g/L 5-ALA in the culture medium with 10g/L glucose as carbon source, this is subsequent fermentation tank Yield and the productivity of continuous feeding raising 5-ALA are laid a good foundation.
Accompanying drawing explanation
Fig. 1 is genetic manipulation target spot.
Fig. 2 A is the digestion verification collection of illustrative plates of plasmid pXA, and Fig. 2 B is plasmid pEP2tuf-rhtA digestion verification collection of illustrative plates.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention will be further described, and following embodiment is the technology in order to make this area Personnel better understood when the present invention, but is not intended to be limited in any the present invention.
Used in the present invention:
Original strain Corynebacterium glutamicum (C.glutamicum) ATCC 13032 is purchased from ATCC (American Type Culture Collection, http://www.atcc.org/);
E.coli MG1655 be purchased from CGSC (Coli Genetic Stock Center, http: // cgsc.biology.yale.edu/)。
Original plasmid pK18mobsacB, pEC-XK99E, pXMJ19 and pEP2 buy in BioVector NTCC company (http://www.biovector.net/)。
5-ALA standard substance are from sigma company (http://www.sigmaaldrich.com/sigma- Aldrich) buy.Restricted enzyme used, dephosphorylation enzyme, DNA ligase equimolecular biological reagent are public from Thermo Department buys (http://www.thermoscientificbio.com/fermentas), and other biochemical reagents used are raw from raw work Thing engineering (Shanghai) limited company buys (http://www.sangon.com/).
Embodiment 1: knock out the structure of plasmid pD-sacB
First the pK18mobsacB linear fragment after cutting using HindIII is as template, with following primer sacB-1 (SEQ ID NO.1)/sacB-2 (SEQ ID NO.2) expands sacB gene.By sacB genetic fragment after MunI/EcoRV double digestion It is attached with the plasmid pEC-XK99E after EcoRI/SmalI double digestion, obtains plasmid pEC-XK99E-sacB.With such as Under primer trcsacB-1 (SEQ ID NO.3)/trcsacB-2 (SEQ ID NO.4), with pEC-XK99E-sacB plasmid make The trcsacB fragment of trc promoter is contained for template amplification.
With following primer pD-1 (SEQ ID NO.5)/pD-2 (SEQ ID NO.6), using pK18mobsacB plasmid as Template amplification contains the pD fragment of kalamycin resistance and escherichia coli replicon, finally by the fragment through AatII enzyme action TrcsacB is attached with the pD fragment through identical enzyme action, obtains plasmid pD-sacB.
Embodiment 2: lactic dehydrogenase enzyme coding gene ldhA knock out with acetic acid constructive ways gene pta-ackA, pqo and Cat knocks out
Lactic dehydrogenase enzyme coding gene ldhA knocks out:
With Corynebacterium glutamicum (C.glutamicum) ATCC 13032 genome as template, with ldh-1 (SEQ ID NO.7)/ldh-2 (SEQ ID NO.8) is the fragment upstream of primer amplification gene ldhA, ldh-3 (SEQ ID NO.9)/ldh-4 (SEQ ID NO.10) is the segments downstream of primer amplification gene ldhA.After two fragments are cut glue recovery, with equimolar ratio Fragment be template, with ldh-1/ldh-4 as primer, amplification obtains the fusion product of two fragments.Fragment after merging is used EcoRI/HindIII double digestion with through as pD-sacB after double digestion connect, obtain plasmid pD-ldhA.
PD-ldhA plasmid is transferred in Corynebacterium glutamicum (C.glutamicum) ATCC 13032, uses kanamycin The screening successful positive colony of restructuring, the transformant chosen is inoculated in 5mL BHIS fluid medium, and 30 DEG C, 220rpm is overnight Cultivate, bacterium solution is diluted certain multiple and is coated on BHIS-Sucrose solid plate.By the bacterium colony that grows on flat board to point The BHIS solid plate of nonreactive and the BHIS solid plate containing 25 μ g/mL kanamycin.Select on nonreactive flat board growth and The colony inoculation that kanamycin flat board does not grows, in 5mL BHIS fluid medium, extracts genome, uses primer ldh-1/ Ldh-4 carries out PCR checking, obtains ldhA gene knock-out bacterial strain CB1.
Knocking out of pta-ackA operon
With C.glutamicum ATCC13032 genome as template, with ackA-1 (SEQ ID NO.11)/ackA-2 (SEQ ID NO.12) is the fragment upstream of primer amplification operon pta-ackA, ackA-3 (SEQ ID NO.13)/ackA-4 (SEQ ID NO.14) is the segments downstream of primer amplification operon pta-ackA.Two fragments are cut glue reclaim after, with etc. rub Your fragment of ratio is template, and with ackA-1/ackA-4 as primer, amplification obtains the fusion product of two fragments.After merging Fragment SalI/XbaI double digestion with through as pD-sacB plasmid after double digestion connect, obtain pta-ackA operon Knock out plasmid pD-pta.
Being transferred in bacterial strain CB1 by pD-pta plasmid, with the kanamycin screening successful positive colony of restructuring, that chooses turns Beggar is inoculated in 5mL BHIS fluid medium, 30 DEG C, 220rpm incubated overnight, bacterium solution dilutes certain multiple and is coated on On BHIS-Sucrose solid plate.The bacterium colony grown on flat board to the BHIS solid plate of a nonreactive and is contained 25 μ g/mL The BHIS solid plate of kanamycin.Select growth on nonreactive flat board and colony inoculation that kanamycin flat board does not grows arrives In 5mL BHIS fluid medium, extract genome, use primer ackA-1/ackA-4 to carry out PCR checking, obtain pta-ackA Operon knock-out bacterial strain CB2.
Knocking out of pqo gene
With C.glutamicum ATCC13032 genome as template, with pqo-1 (SEQ ID NO.15)/pqo-2 (SEQ ID NO.16) it is the fragment upstream of primer amplification pqo gene, pqo-3 (SEQ ID NO.17)/pqo-4 (SEQ ID NO.18) Segments downstream for primer amplification pqo.Two fragments are cut after glue reclaims, with the fragment of equimolar ratio as template, with pqo- 1/pqo-4 is primer, and amplification obtains the fusion product of two fragments.Fragment XbaI/PstI double digestion and warp after merging Crossing the pD-sacB after same double digestion to connect, obtain pqo gene knocks out plasmid pD-pqo.
Being transferred in bacterial strain CB2 by pD-pqo plasmid, with the kanamycin screening successful positive colony of restructuring, that chooses turns Beggar is inoculated in 5mL BHIS fluid medium, 30 DEG C, 220rpm incubated overnight, bacterium solution dilutes certain multiple and is coated on On BHIS-Sucrose solid plate.The bacterium colony grown on flat board to the BHIS solid plate of a nonreactive and is contained 25 μ g/mL The BHIS solid plate of kanamycin.Select growth on nonreactive flat board and colony inoculation that kanamycin flat board does not grows arrives In 5mL BHIS fluid medium, extract genome, use primer pqo-1/pqo-4 to carry out PCR checking, obtain pqo gene Knock-out bacterial strain CB3.
Knocking out of cat gene
With C.glutamicum ATCC13032 genome as template, with cat-1 (SEQ ID NO.19)/cat-2 (SEQ ID NO.20) it is the fragment upstream of primer amplification cat gene, cat-3 (SEQ ID NO.21)/cat-4 (SEQ ID NO.22) Segments downstream for primer amplification cat.Two fragments are cut after glue reclaims, with the fragment of equimolar ratio as template, with cat- 1/cat-4 is primer, and amplification obtains the fusion product of two fragments.Fragment XbaI/SalI double digestion and warp after merging Crossing the pD-sacB after same double digestion to connect, obtain cat gene knocks out plasmid pD-cat.
Being transferred in bacterial strain CB3 by pD-cat plasmid, with the kanamycin screening successful positive colony of restructuring, that chooses turns Beggar is inoculated in 5mL BHIS fluid medium, 30 DEG C, 220rpm incubated overnight, bacterium solution dilutes certain multiple and is coated on On BHIS-Sucrose solid plate.The bacterium colony grown on flat board to the BHIS solid plate of a nonreactive and is contained 25 μ g/mL The BHIS solid plate of kanamycin.Select growth on nonreactive flat board and colony inoculation that kanamycin flat board does not grows arrives In 5mL BHIS fluid medium, extract genome, use primer cat-1/cat-4 to carry out PCR checking, obtain cat gene Knock-out bacterial strain CB4.
Wherein BHIS medium component is (g/L): Medulla Bovis seu Bubali heart leaching powder 37, sorbitol 91.
BHIS solid culture based component is (g/L): Medulla Bovis seu Bubali heart leaching powder 37, sorbitol 91, agar 2% (W/V)
BHIS-Sucrose solid medium (g/L): Medulla Bovis seu Bubali heart leaching powder 37, sorbitol 91, agar 2% (W/V), sugarcane
Sugar 10% (W/V).
Embodiment 3: be previously inserted into strong sod promoter and PCK coding base at ppc gene Because of knocking out of pck gene
Ppc gene is previously inserted into strong sod promoter
With C.glutamicum ATCC13032 genome as template, with ppc-1 (SEQ ID NO.23)/ppc-2 (SEQ ID NO.24) it is the fragment upstream of primer amplification gene ppc.sod-1(SEQ ID NO.25)/sod-2(SEQ ID NO.26) For expanding the promoter of sod gene.Ppc-3 (SEQ ID NO.27)/ppc-4 (SEQ ID NO.28) is used for expanding ppc base 3 fragments are cut after glue reclaims, with the fragment of equimolar ratio as template, with ppc-1/ppc-4 are by the segments downstream of cause respectively Primer, amplification obtains the fusion product of three fragments.Fragment after merging is with same with process after XbaI/HindIII double digestion Plasmid vector pD-sacB after sample double digestion connects.Obtain plasmid pD-ppc.
Electricity is utilized to be transferred in bacterial strain CB4 the plasmid built, with the most positive gram of kanamycin screening restructuring Grand, the transformant chosen is inoculated in 5mL BHIS fluid medium, 30 DEG C, 220rpm incubated overnight, by certain for bacterium solution dilution Multiple be coated on BHIS-Sucrose solid plate.By the bacterium colony that grows on flat board to the BHIS solid plate of a nonreactive and BHIS solid plate containing 25 μ g/mL kanamycin.The bacterium that kanamycin flat board does not grows by growth on nonreactive flat board Fall to being inoculated in 5mL BHIS fluid medium, extract genome, send order-checking, obtain being previously inserted into sod promoter at ppc gene Bacterial strain CB5.
Knocking out of pck gene
With C.glutamicum ATCC 13032 genome as template, carry out PCR amplification with following primer.pck-1(SEQ ID NO.29)/pck-2 (SEQ ID NO.30) is for the fragment upstream of amplification gene pck.pck-3(SEQ ID NO.31)/ Pck-4 (SEQ ID NO.32) is for the segments downstream of amplification gene pck.By fragment upstream after EcoRI/XbaI double digestion It is connected with the pD-sacB plasmid after identical double digestion, obtains plasmid pD-pck (F), plasmid pD-pck (F) warp that will build It is attached with the segments downstream through PstI/HindIII double digestion after crossing PstI/HindIII double digestion, obtains pD-pck matter Grain.
This plasmid is transferred in bacterial strain CB5, by the kanamycin screening successful positive colony of restructuring, the transformant chosen It is inoculated in 5mL BHIS fluid medium, 30 DEG C, 220rpm incubated overnight, bacterium solution is diluted certain multiple and is coated on On BHIS-Sucrose solid plate.The bacterium colony grown on flat board to the BHIS solid plate of a nonreactive and is contained 25 μ g/mL The BHIS solid plate of kanamycin.The colony inoculation that kanamycin flat board does not grows by growth on nonreactive flat board arrives In 5mLBHIS fluid medium, extract genome, use primer pck-1/pck-4 to carry out PCR checking, obtainpckStriking of gene Degerming strain CB6.
Embodiment 4: plasmid pXA and pEP2tufThe structure of-rhtA
The structure of pXA plasmid
By the 5-Aminolevulinate synthase gene hemA of hydrogenlike silicon ion (Rhodobacter sphaeroides) according to The codon preference of Corynebacterium glutamicum carries out codon optimized, and the method for the gene full genome synthesis after optimizing is carried out Synthesis (as shown in SEQ ID NO.39), utilizes primer hemA-1 (SEQ ID NO.33)/hemA-2 (SEQ ID NO.34) to expand Increase the hemA fragment after optimizing, by the hemA fragment that obtains after PstI/XbaI double digestion with after identical double digestion Shuttle plasmid pXMJ19 connects, and obtains pXA plasmid, and Fig. 2 A is the digestion verification collection of illustrative plates of plasmid pXA.
With C.glutamicum ATCC 13032 genome as template, with tuf-1 (SEQ ID NO.35)/tuf-2 (SEQ ID NO.36) be primer amplification tuf promoter, by after tuf fragment EcoRI/SalI enzyme action with the pEP2 through identical enzyme action Plasmid connects, and obtains the low copy plasmid pEP2 with tuf promotertuf.With E.coli MG1655 genome as template, use RhtA-1 (SEQ ID NO.37)/rhtA-2 (SEQ ID NO.38) is primer amplification rhtA fragment, by fragment XbaI/ With the pEP2 through identical enzyme action after BamHI double digestiontufPlasmid is attached, and obtains pEP2tuf-rhtA plasmid, Fig. 2 B is matter Grain pEP2tuf-rhtA digestion verification collection of illustrative plates.
Import to, in bacterial strain CB6, utilize chloromycetin to screen by the pXA plasmid built, obtain with pXA plasmid Strains A L1.The pEP2 that will buildtuf-rhtA plasmid utilizes electricity to turn and imports in AL1, utilize chloromycetin and kanamycin to carry out Screening, obtains final 5-ALA and produces strains A L2.
Fig. 1 is shown in the genetic manipulation that the present invention relates to, and in Fig. 1, " X " expression knocks out, and underscore represents process LAN.
Table 1 strain construction the primer sequence
Embodiment 5: utilize the bacterial strain built to carry out the shake flask fermentation of 5-ALA
Strains A L2 built is fermented in shaking flask.
Concrete fermentation mode is as follows
Vaccination ways is: first activated strains on BHIS solid plate, 30 DEG C cultivate to bacterium colony can apparent time, choose single bacterium Fall the BHIS liquid of the chloromycetin being seeded to the kanamycin sulfate equipped with the final concentration of 25 μ g/mL of 5mL and final concentration of 10 μ g/mL After body culture medium cultivates 15h, it is transferred in M1 culture medium, when cultivating to logarithm middle and late stage, seed is inoculated into M2 and cultivates In base.Culture medium is added the isopropylthio-β-D-galactoside of final concentration of 0.5mM as derivant.After fermentation ends It is 2.78g/L that detection generates the yield of 5-ALA.
M1 medium component is (g/L): glucose 10, yeast extract 10, tryptone 10, NaCl 2.5.
M2 medium component is (g/L): glucose 10, yeast extract 10, tryptone 10, NaCl 2.5,3-(N- Quinoline) propane sulfonic acid 21, glycine 7.5.

Claims (3)

1. produce a construction method for the Corynebacterium glutamicum strain of 5-ALA, it is characterized in that including walking as follows Rapid:
(1) in Corynebacterium glutamicum (C.glutamicum) ATCC 13032, lactic dehydrogenase enzyme coding gene ldhA and second are knocked out Acid generates gene pta-ackA, pqo and cat, and the Strain Designation obtained is CB4;Phosphoenolpyruvic acid in CB4 bacterial strain Carboxylase encoding gene ppc is previously inserted into strong sod promoter, obtains bacterial strain CB5;Phosphoenolpyruvate is knocked out in CB5 bacterial strain Pyruvate carboxykinase encoding gene pck, obtains bacterial strain CB6;
(2) by the plasmid pXA of process LAN 5-Aminolevulinate synthase gene built and process LAN RhtA transport protein Plasmid pEP2tuf-rhtA is transferred in CB6 bacterial strain, it is thus achieved that produce the Corynebacterium glutamicum strain AL2 of 5-ALA.
2. the Corynebacterium glutamicum strain AL2 producing 5-ALA that the method described in claim 1 builds.
3. the purposes of the Corynebacterium glutamicum strain AL2 producing 5-ALA of claim 2.
CN201610408674.4A 2016-06-03 2016-06-03 Corynebacterium glutamicum strain for production of 5-aminolevulinic acid and construction and application of corynebacterium glutamicum strain Pending CN106047916A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610408674.4A CN106047916A (en) 2016-06-03 2016-06-03 Corynebacterium glutamicum strain for production of 5-aminolevulinic acid and construction and application of corynebacterium glutamicum strain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610408674.4A CN106047916A (en) 2016-06-03 2016-06-03 Corynebacterium glutamicum strain for production of 5-aminolevulinic acid and construction and application of corynebacterium glutamicum strain

Publications (1)

Publication Number Publication Date
CN106047916A true CN106047916A (en) 2016-10-26

Family

ID=57170743

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610408674.4A Pending CN106047916A (en) 2016-06-03 2016-06-03 Corynebacterium glutamicum strain for production of 5-aminolevulinic acid and construction and application of corynebacterium glutamicum strain

Country Status (1)

Country Link
CN (1) CN106047916A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106434514A (en) * 2016-11-09 2017-02-22 天津大学 Corynebacterium glutamicum engineering strain for producing 5-aminolevulinic acid
CN106434513A (en) * 2016-11-09 2017-02-22 天津大学 Corynebacterium glutamicum recombinant strain for producing 5-aminolevulinic acid
CN107012161A (en) * 2017-04-03 2017-08-04 天津大学 Corynebacterium glutamicum and structure and application using stalk hydrolyzate high yield butanedioic acid
CN108517327A (en) * 2018-04-20 2018-09-11 中国科学院天津工业生物技术研究所 5-ALA superior strain and its preparation method and application
WO2020186326A1 (en) * 2019-03-21 2020-09-24 De Leao Rosenmann Bernardo Cosmetic formulations formed by a nutritive mixture from a fermentative process
WO2020232519A1 (en) * 2019-05-22 2020-11-26 De Leao Rosenmann Bernardo Nutritional compound formed by bacterial fermentation content for use as a supplement or additive for animal feed
CN115044602A (en) * 2022-05-23 2022-09-13 天津大学 Strain for anaerobic synthesis of corynebacterium 5-aminolevulinic acid glutamate and construction method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103710374A (en) * 2014-01-14 2014-04-09 中国科学院天津工业生物技术研究所 Bacterial strain produced by 5-aminolevulinic acid as well as preparation method and application thereof
CN103981203A (en) * 2013-02-07 2014-08-13 中国科学院天津工业生物技术研究所 5-amino levulinic acid (ALA) high-yield strain and preparation method and application thereof
CN104928226A (en) * 2015-07-17 2015-09-23 山东大学 Recombined corynebacterium glutamicum and application of corynebacterium glutamicum to 5-aminolevulinic acid production

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103981203A (en) * 2013-02-07 2014-08-13 中国科学院天津工业生物技术研究所 5-amino levulinic acid (ALA) high-yield strain and preparation method and application thereof
CN103710374A (en) * 2014-01-14 2014-04-09 中国科学院天津工业生物技术研究所 Bacterial strain produced by 5-aminolevulinic acid as well as preparation method and application thereof
CN104928226A (en) * 2015-07-17 2015-09-23 山东大学 Recombined corynebacterium glutamicum and application of corynebacterium glutamicum to 5-aminolevulinic acid production

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LILI FENG ET AL: "Metabolic Engineering of Corynebacterium glutamicum for Efficient Production of 5-Aminolevulinic Acid", 《BIOTECHNOL. BIOENG》 *
ZHEN KANG ET AL: "Engineering Escherichia coli for efficientproductionof5-aminolevulinicacid from glucose", 《METABOLIC ENGINEERING》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106434514A (en) * 2016-11-09 2017-02-22 天津大学 Corynebacterium glutamicum engineering strain for producing 5-aminolevulinic acid
CN106434513A (en) * 2016-11-09 2017-02-22 天津大学 Corynebacterium glutamicum recombinant strain for producing 5-aminolevulinic acid
CN107012161A (en) * 2017-04-03 2017-08-04 天津大学 Corynebacterium glutamicum and structure and application using stalk hydrolyzate high yield butanedioic acid
CN108517327A (en) * 2018-04-20 2018-09-11 中国科学院天津工业生物技术研究所 5-ALA superior strain and its preparation method and application
WO2020186326A1 (en) * 2019-03-21 2020-09-24 De Leao Rosenmann Bernardo Cosmetic formulations formed by a nutritive mixture from a fermentative process
WO2020232519A1 (en) * 2019-05-22 2020-11-26 De Leao Rosenmann Bernardo Nutritional compound formed by bacterial fermentation content for use as a supplement or additive for animal feed
CN115044602A (en) * 2022-05-23 2022-09-13 天津大学 Strain for anaerobic synthesis of corynebacterium 5-aminolevulinic acid glutamate and construction method

Similar Documents

Publication Publication Date Title
CN106047916A (en) Corynebacterium glutamicum strain for production of 5-aminolevulinic acid and construction and application of corynebacterium glutamicum strain
JP6961819B2 (en) Recombinant bacteria that produce L-lysine, its construction method and L-lysine production method
CN103981203B (en) 5 amino-laevulic acid superior strains and its preparation method and application
CN103403147B (en) The microorganism producing putrescine and the method using this micro-organisms putrescine
CN100379851C (en) Microorganism producing l-threonine, method of producing the same and method of producing l-threonine using the microorganism
JP2021500914A5 (en)
CN102165056B (en) Microorganism for producing L-amino acids and method for producing L-amino acids using same
CN104004701B (en) Method for building high-yield 5-aminolevulinic acid escherichia coli engineering strains
CN106434510B (en) One plant of fermentation produces the genetic engineering bacterium of L-Aspartic acid
CN107787361A (en) Generate the mutant microbial of L aspartames and the method using mutant microbial generation L aspartames
CN114958888B (en) Valine-producing strain and construction method thereof
CN105886449A (en) Recombinant escherichia coli and application thereof in production of L-methionine
WO2022174597A1 (en) Genetically engineered bacterium for producing l-sarcosine, construction method therefor and use thereof
CN106636171A (en) Crynebacterium glutamicum engineering strain for producing 5-aminolevulinic acid and construction method thereof+
CN107236752A (en) The construction method of recombination bacillus coli and the method for fermenting and producing beta Alanine
CN104830748B (en) A kind of reduction hemB gene expressions improve the method that Escherichia coli synthesize 5 amino-laevulic acids
CN108531437A (en) A kind of 5-ALA biosynthesis pathway that Glyoxylate transaminase mediates
CN106434513A (en) Corynebacterium glutamicum recombinant strain for producing 5-aminolevulinic acid
CN106434514A (en) Corynebacterium glutamicum engineering strain for producing 5-aminolevulinic acid
CN112442471B (en) Escherichia coli engineering bacterium with strong acid stress resistance and application thereof
CN112391329B (en) Escherichia coli engineering bacteria with improved acid stress resistance and application thereof
CN108315289A (en) A method of improving glycolic yield in Escherichia coli
CN104017767B (en) A kind of method utilizing combinatorial regulation strategy to improve 5-ALA yield
CN114426983B (en) Method for producing 5-aminolevulinic acid by knocking out transcription regulatory factor Ncgl0580 in corynebacterium glutamicum
ZA200507688B (en) TDCBC/PCKA gene-inactivated microorganism and met hod of producing I-threonine using the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20161026